Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10357176rdf:typepubmed:Citationlld:pubmed
pubmed-article:10357176lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:10357176lifeskim:mentionsumls-concept:C0227525lld:lifeskim
pubmed-article:10357176lifeskim:mentionsumls-concept:C0521119lld:lifeskim
pubmed-article:10357176lifeskim:mentionsumls-concept:C1510411lld:lifeskim
pubmed-article:10357176lifeskim:mentionsumls-concept:C0016693lld:lifeskim
pubmed-article:10357176lifeskim:mentionsumls-concept:C1413700lld:lifeskim
pubmed-article:10357176lifeskim:mentionsumls-concept:C1422342lld:lifeskim
pubmed-article:10357176lifeskim:mentionsumls-concept:C0301630lld:lifeskim
pubmed-article:10357176pubmed:issue6lld:pubmed
pubmed-article:10357176pubmed:dateCreated1999-7-9lld:pubmed
pubmed-article:10357176pubmed:abstractTextRedox activities associated with plasma membranes of nonphagocytic animal and plant cells have been reported by several authors. However, the natural substrates, structure and biological role of these putative enzyme systems are not known. Data indicating extracellular reduction of a nitroxide free radical Cat1 (1-oxy-4-trimethylamine-2,2,6,6,tetramethyl-piperidine) by hepatocytes were thought to be artefactual. We report evidence in support of a notion that Cat1 as well as a tetrazolium salt, CTC (5-cyano-2,3-ditolyl tetrazolium chloride), are reduced extracellularly, probably at the cell surface, by human HepG2 hepatoma cells. These data provide evidence confirming the existence of a yet unidentified reducing activity associated with outer surface of plasma membranes of transformed human hepatocytes.lld:pubmed
pubmed-article:10357176pubmed:languageenglld:pubmed
pubmed-article:10357176pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10357176pubmed:citationSubsetIMlld:pubmed
pubmed-article:10357176pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10357176pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10357176pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10357176pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10357176pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10357176pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10357176pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10357176pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10357176pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10357176pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10357176pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10357176pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10357176pubmed:statusMEDLINElld:pubmed
pubmed-article:10357176pubmed:monthDeclld:pubmed
pubmed-article:10357176pubmed:issn0144-8463lld:pubmed
pubmed-article:10357176pubmed:authorpubmed-author:DobruckiJJlld:pubmed
pubmed-article:10357176pubmed:authorpubmed-author:BernasTTlld:pubmed
pubmed-article:10357176pubmed:issnTypePrintlld:pubmed
pubmed-article:10357176pubmed:volume18lld:pubmed
pubmed-article:10357176pubmed:ownerNLMlld:pubmed
pubmed-article:10357176pubmed:authorsCompleteYlld:pubmed
pubmed-article:10357176pubmed:pagination341-50lld:pubmed
pubmed-article:10357176pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:10357176pubmed:meshHeadingpubmed-meshheading:10357176...lld:pubmed
pubmed-article:10357176pubmed:meshHeadingpubmed-meshheading:10357176...lld:pubmed
pubmed-article:10357176pubmed:meshHeadingpubmed-meshheading:10357176...lld:pubmed
pubmed-article:10357176pubmed:meshHeadingpubmed-meshheading:10357176...lld:pubmed
pubmed-article:10357176pubmed:meshHeadingpubmed-meshheading:10357176...lld:pubmed
pubmed-article:10357176pubmed:meshHeadingpubmed-meshheading:10357176...lld:pubmed
pubmed-article:10357176pubmed:meshHeadingpubmed-meshheading:10357176...lld:pubmed
pubmed-article:10357176pubmed:meshHeadingpubmed-meshheading:10357176...lld:pubmed
pubmed-article:10357176pubmed:meshHeadingpubmed-meshheading:10357176...lld:pubmed
pubmed-article:10357176pubmed:meshHeadingpubmed-meshheading:10357176...lld:pubmed
pubmed-article:10357176pubmed:meshHeadingpubmed-meshheading:10357176...lld:pubmed
pubmed-article:10357176pubmed:meshHeadingpubmed-meshheading:10357176...lld:pubmed
pubmed-article:10357176pubmed:meshHeadingpubmed-meshheading:10357176...lld:pubmed
pubmed-article:10357176pubmed:meshHeadingpubmed-meshheading:10357176...lld:pubmed
pubmed-article:10357176pubmed:meshHeadingpubmed-meshheading:10357176...lld:pubmed
pubmed-article:10357176pubmed:meshHeadingpubmed-meshheading:10357176...lld:pubmed
pubmed-article:10357176pubmed:meshHeadingpubmed-meshheading:10357176...lld:pubmed
pubmed-article:10357176pubmed:year1998lld:pubmed
pubmed-article:10357176pubmed:articleTitleExtracellular reduction of Cat1 free radical by transformed human hepatocytes.lld:pubmed
pubmed-article:10357176pubmed:affiliationDepartment of Biophysics, Institute of Molecular Biology, Jagiellonian University, Krakow, Poland.lld:pubmed
pubmed-article:10357176pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10357176pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed